“Stephanie has a sharp mind, she understands the corporate and strategic goals of the client. She is creative and very responsive, there’s always a sense that we are prioritized.”
— Chambers USA 2026
Stephanie Lodise is a seasoned patent attorney with more than 18 years of experience guiding life sciences companies through the complex landscape of U.S. and international patent law. As co-Chair of the firm’s Life Sciences Industry team, she partners with pharmaceutical innovators of all sizes to strategically build, strengthen and defend high-value patent portfolios.
Stephanie’s practice centers on life sciences patent prosecution, with a particular emphasis on small molecule therapeutics, drug repositioning, antibody-drug conjugates and isotopically labeled pharmaceuticals. She is highly skilled in freedom-to-operate (FTO) analyses, patent landscape evaluations, 505(b)(2) product protection, IP due diligence, portfolio development, post-grant proceedings PTAB appeals and regulatory aligned IP strategies, including Orange Book listings and Patent Term Extension Application. Stephanie’s Ph.D. in synthetic organic chemistry and prior experience as a research chemist brings deep scientific insight and technical fluency to her legal practice, especially in terms of aligning commercial goals with regulatory pathways. Her work has supported the protection and commercialization of numerous FDA-approved products, including Amyvid®, Austedo®, Bendeka®, Ekterly®, Erleada®, Impoyz®, Olysio®, Prezista®, Treanda® and Uzedy®.
